| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.069 | 0.4 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.047 | 0.4 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.064 | 0.4 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.4 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |